NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-242-2001-0-PCT-02 FOLDED MONOMERS OF THE HIV-1 PROTEASE AND METHODS OF THEIR USE PCT PCT PCT/US02/26757 Abandoned
NCI E-198-2001-0-PCT-02 Use of a Histone Deacetylase Inhibitor to Increase The Entry of an Adenoviral Agent Into a Cell PCT PCT PCT/US02/26908 Expired
NIDCR E-320-2001-0-EP-04 METHODS OF INHIBITING FORMATION OF VASCULAR CHANNELS AND METHODS OF INHIBITING PROLIFERATION EP National Stage 02757347.6 Abandoned
NIDCR E-320-2001-0-CA-05 METHODS OF INHIBITING FORMATION OF VASCULAR CHANNELS AND METHODS OF INHIBITING PROLIFERATION CA National Stage 2456269 Abandoned
NCI E-086-2001-1-PCT-01 PEPTIDES OF A MELANOMA ANTIGEN AND THEIR USE IN DIAGNOSTIC, PROPHYLACTIC AND THERAPEUTIC METHODS PCT PCT COMB PCT/US2002/026957 Expired
NCI E-273-2002-0-US-01 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE US ORD 10/226,412 6936639 Expired PDF
NCI E-284-2002-0-US-01 Universal Detector and Adaptor for Microelectric Nanochip SNP Detection US 60/404,777 Abandoned
NCI E-304-2000-0-US-01 ABCA13 Nucleic Acids and Proteins, and Uses Thereof US 60/405,006 Abandoned
NINDS E-303-2001-0-US-01 Method for Production of Human Insulin Producing Cells US 60/404,578 Abandoned
NCI E-173-2001-0-US-01 HTLV-1 p30II AND p12 PROTEINS AS THERAPEUTIC TARGETS IN HTLC-1 INFECTED INDIVIDUALS US 60/404,580 Abandoned
NCI E-277-2002-1-US-01 Methods, Compositions and Systems for the Identification and Characterization of Cytochrome bc1 Inhibitors US 60/404,146 Abandoned
NIDDK E-222-2002-0-US-01 A Method of Inducing Differentiation By Inhibiting Proliferation of Precursor/Progenitor Cells and of Treating Diabetes by Cell... US 60/404,577 Abandoned
NCI E-317-2002-0-EP-04 Molecular Characteristics of Non-Small Cell Lung Cancer EP National Stage 02794901.5 Expired
NCI E-200-1990-4-HK-09 GENERATION OF IMMUNE RESPONSES TO PROSTATE-SPECIFIC ANTIGEN (PSA) HK National Stage 02103565.7 Expired
NINDS E-092-1993-1-US-04 CELL TESTS FOR ALZHEIMER'S DISEASE US CON 10/222,344 Abandoned
NCI E-317-2002-0-JP-05 Molecular Characteristics of Non-Small Cell Lung Cancer JP National Stage 2003-520378 Expired
CC E-248-2001-0-US-01 Apparatus for Multifocal Deposition and Analysis and Methods for its Use US 60/403,875 Abandoned
NCI E-342-2003-0-US-01 Hepatitis C Viral-Like Particle Purification US 60/404,183 Abandoned
NCI E-317-2002-0-CA-06 Molecular Characteristics of Non-Small Cell Lung Cancer CA National Stage 2456334 Abandoned
NCI E-317-2002-0-PCT-02 Molecular Characteristics of Non-Small Cell Lung Cancer PCT PCT PCT/US02/026027 Expired
NIAAA E-321-2001-0-PCT-02 Novel Vasoconstrictor Cannabinoid Analogs PCT PCT PCT/US02/26050 Expired
NHLBI E-325-2001-1-US-01 Production of Adeno-Associated Virus in Insect Cells US CIP 10/216,870 6723551 Expired PDF
NIDDK E-323-2002-2-US-01 Novel Combination Therapy to Treat Glaucoma US CIP 10/217,755 Abandoned
NIEHS E-129-2004-0-PCT-03 Thermostable UvrA, UvrB, Adn UvrC Polypeptides And Methods Of Use PCT PCT PCT/US02/25567 Expired
NIEHS E-129-2004-0-PCT-02 Thermostable UvrA, UvrB, And UvrC Polypeptides and Methods of Use PCT PCT PCT/US02/25474 Abandoned
NEI E-185-1992-2-US-04 RETINAL PIGMENTED EPITHELUIM DERIVED NEUROTROPHIC FACTOR US DIV 10/216,373 7511009 Expired PDF
NIAID E-095-2000-0-US-03 IDENTIFICATION OF A NOVEL DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION. US National Stage 10/203,495 7148061 Expired PDF
NCI E-009-2000-0-US-21 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof US CON 10/203,675 7129332 Abandoned PDF
CC E-229-1999-0-US-04 Vessel Delineation in Magnetic Resonance Angiographic Images US National Stage 10/203,662 7003144 Abandoned PDF
NHLBI E-108-2001-0-PCT-02 Side-exit Catheter Fand Method for Its Use PCT PCT PCT/US02/25494 Abandoned
NHGRI E-002-1998-0-US-03 TUMOR TISSUE MICROARRAYS FOR RAPID MOLECULAR PROFILING US DIV 10/215,762 Abandoned
NIDCR E-268-2002-0-US-01 Creation of Stable Recombinant Protective Antigen (RPA) Molecule by Deletions of the Chymotryspin-Sensitive Loop and the Furin -Cleavage Loop US 60/402,285 Abandoned
NIAID E-355-2001-1-US-01 VAC-BAC Shuttle Vector System US 60/402,824 Abandoned
NEI E-345-2001-0-US-01 TRANSKETOLASE AS A THERAPEUTIC AND DIAGNOSTIC TARGET US 60/402,365 Abandoned
NCI E-009-2000-0-NZ-13 Anti-EGFRvIII SCFVS with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof NZ National Stage 2052-06-22 Abandoned
NCI E-009-2000-0-CN-15 Anti-EGFRvIII scFvs with Improved Cytotoxicity and Yield, Immunotoxins Based Thereon, and Methods of Use Thereof CN National Stage 01807175.9 Abandoned
NICHD E-280-2002-0-US-01 Measurement Systems and Methods US 60/401,935 Abandoned
NCI E-088-2001-0-PCT-02 Diacylglycerol Mimetics And Methods of Using The Same as Protein Kinase C Alpha Activators And Apoptosis Inducers PCT PCT PCT/US02/25088 Abandoned
NCI E-277-2002-0-US-01 Structure of famoxadone in complex with cytochrome bc1 complex US 60/401,039 Abandoned
NCI E-025-1999-0-US-03 Interleukin-2 Receptor Associated Polypeptides US National Stage 10/089,009 Abandoned
NCI E-254-1999-0-US-03 New Tumor Suppressor Gene, p47ING3 US National Stage 10/203,532 7335749 Abandoned PDF
NIAID E-281-2001-0-PCT-02 Oral Treatment of Hemophilia PCT PCT PCT/US2002/024544 Expired
NINDS E-296-2000-0-US-02 Intercellular Delivery of a Herpes Simplex Virus VP22 Fusion Protein from Cells Infected with Lentriviral Vectors US ORD 10/212,634 Abandoned
NIAID E-281-2001-0-EP-04 Oral Treatment of Hemophilia EP National Stage 02756904.5 Abandoned
NCI E-306-2000-0-US-01 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITION COMPRISING SAME AND METHODS OF MAKING SAME. US 60/400,817 Abandoned
NCI E-059-2003-0-US-01 Use Of Layered Expression Scanning (LES) For Multiwell Plates US 60/400,874 Abandoned
NCI E-230-1997-0-AU-04 Human Papilloma Virus Inhibition By Anti-Sense Oligonucleotides AU DIV 2002300401 Abandoned
NCI E-052-1995-1-AU-08 METHOD FOR INCREASING THE ANTIGEN PRESENTING ABILITY OF LEUKEMIA CELLS AU National Stage 2002300335 Abandoned
NCI E-230-1997-0-AU-10 Human Papilloma Virus Inhibition By Anti-Sense Oligonucleotides AU DIV 2002300399 Abandoned
NIA E-049-2001-0-CA-05 GLP-1 EXENDIN-4 PEPTIDE ANALOGS AND USES THEREOF CA National Stage 2455963 Expired